Traferox Wins FDA Clearance for 10°C Heart Preservation System
Following the FDA clearance, Traferox will begin making 10°C heart preservation available to transplant centres across the United States.
E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
Following the FDA clearance, Traferox will begin making 10°C heart preservation available to transplant centres across the United States.
Traferox’s TorEx Lung Perfusion System allows donor lungs to be evaluated outside the body before transplantation, helping clinicians safely utilize organs that might otherwise be rejected.
HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.

